Table 1 Participants’ characteristics.
From: Slowing down in PNP: relationship of joint velocities in an arm-movement test and the fast TUG test
PNP | matched CG | p-value | |
|---|---|---|---|
n = 20 | n = 20 | ||
Age mean ± SD | 60.7 ± 13.9 | 60.4 ± 14.7 | .9391 |
Sex (m: f) N (%) | 15:5 (75:25) | 15:5 (75:25) | 1.0002 |
BMI (kg/m²) mean ± SD | 26.9 ± 5.2 | 25.2 ± 3.9 | .2641 |
Falls [past year] N Faller/non-faller N (%) | 32 13 (65)/7 (35) | 2 2 (10)/18 (90) | 0.0013 |
FES-I [16–64 Points] mean (range)a - Low concern [16–19] N (%) - Moderate concern [20–27] N (%) - High concern [28–64] N (%) | 22.1 (16–38) 9 (45) 6 (30) 5 (25) | 17.4 (16–20) 16 (80) 4 (20) 0 (0) | 0.0063 |
POMA [0–28 Points] mean (range)b - Moderate risk of falling [19–24] N (%) - High risk of falling [10–19] N (%) | 22.6 (10–28) 6 (30) 5 (25) | 27.8 (27–28) 0 (0) 0 (0) | < 0.0013 |
PNP entity N (%) - CIPN - CIDP Not classified | 4 (20) 15 (75) 1 (5) | ||
Disease duration (months) mean (range) | 52.5 (8–256) | ||
PNP specific treatment N (%) - Rituximab - IVIg | 2 (10) 14 (70) | ||
PNP sensorimotor deficits N of 4 (%) - No sensory deficits - 1 deficit - 2 deficits - 3 deficits - 4 deficits - Reduced reflexes AT/PT - Loss of reflexes AT/PT | 4 (20) 7 (35) 2 (10) 5 (25) 2 (10) 10 (50)/6 (30) 4 (20)/8 (40) |
